A pregnancy plan changes the visit

A pregnancy plan changes the visit. A fictional patient uses injectable Wegovy only for weight management. She hopes to start trying to conceive next month and asks whether she can continue until a positive pregnancy test. What needs to change?

For this weight-management use, the current Wegovy prescribing information calls for discontinuation at least two months before a planned pregnancy. Her proposed timeline therefore needs discussion now with the prescribing clinician and obstetric team.

Do not apply one medicine's stopping interval to every GLP-1 treatment. Confirm the product, formulation, indication, dose and last dose. Ask about reproductive plans without making assumptions about age or contraception.

If a patient also has diabetes, stopping a medicine is only one part of the transition. Arrange active glucose management and an agreed treatment plan. Rising glucose or concerning symptoms need timely assessment, not simply a referral placed in the chart.

Explain who will make the medication decision, who is responsible while appointments are pending, and how the patient should contact the team if her plans or health change. Ask her to explain the next step in her own words.

The takeaway is simple: verify the product, apply the appropriate instruction, and preserve ongoing care. The full activity includes the references and the separate contraception and unexpected-exposure cases.